Sleep Number Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Sales Results. Also, Piper Sandler Maintained a Neutral Rating on the Stock and Lowered Its Price Target From $13 to $12.
Sleep Number Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Sales Results. Also, Piper Sandler Maintained a Neutral Rating on the Stock and Lowered Its Price Target From $13 to $12.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.